Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms

NCT: NCT07329673 · SUSPENDED

NCT IDNCT07329673
StatusSUSPENDED
Start Date2026-01-01
SponsorQbtech AB (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate QbMobile's ability to collect objective data to identify specific symptom profiles in differential diagnoses (ASD, MDD, Bipolar Disorder and Anxiety Disorder) that are common with ADHD.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑